investors

Key Ratios

Price & Volume

Recent Price $0.22
Recent Price 9/24/18
52 Week High $0.55
52 Week Low $0.17
5 Day Price Percent Change (%) 4.81%
4 Week Price Percent Change (%) -8.29%
26 Week Price Percent Change (%) -18.48%
52 Week Price Percent Change (%) -37.11%
Volume (3 Month Average) (Mil) 4.14
Volume (10 Day Average) (Mil) 0.24
Beta -0.09

Dividend Information

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Quick Ratio (FY)) --
Current Ratio (MRQ) $9.53
LT Debt to Equity (MRQ) (%) --
LT Debt to Equity (MRQ) (%) --
LT Debt to Equity (FY) (%) --
Total Debt to Equity (MRQ) (%) --
Total Debt to Equity (FY) (%) --

Valuation Ratios

P/E (TTM) --
P/E (FY) --
P/E 5 Fiscal Year High --
P/E 5 Fiscal Year Low --
Price to Revenue (TTM) --
Price to Revenue (MRQ) --
Price to Revenue (FY) --
Price to Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) --
Price to Free Cash Flow (TTM) --
Price to Free Cash Flow (FY) --
Price to Book (MRQ) $2.69
Price to Book (FY) $1.98
Price to Tangible Book (MRQ) $2.69
Price to Tangible Book (FY) $1.99
Price to Tangible Book - Common (MRQ) $3.18
Price to Tangible Book - Common (FY) $2.85

Per Share Data

Revenue/Share (TTM) --
Revenue/Share (MRQ) --
Revenue/Share (FY) --
EPS Fully Diluted (TTM) $-0.48
EPS Fully Diluted (MRQ) $-0.01
Book Value/Share (MRQ) $0.08
Book Value/Share (FY) $0.11
Cash Flow/Share (TTM) $-0.27
Cash Flow/Share (MRQ) $-0.03
Cash Flow/Share (FY) $-1.22
Cash (MRQ) $0.07
Cash (FY) $0.16

Mgmt Effectiveness

Return on Equity (TTM) (%) -3,687.44
Return on Equity (MRQ) (%) -34.66
Return on Equity (FY) (%) -328.04
Return on Assets (TTM) (%) -131.11
Return on Assets (MRQ) (%) -27.36
Return on Assets (FY) (%) -119.77
Return on Investment (TTM) (%) -2,187.58
Return on Investment (MRQ) (%) -34.66
Return on Investment (FY) (%) -156.42

Profitability

Operating Margin (TTM) (%) --
Operating Margin (MRQ) (%) --
Operating Margin (FY) (%) --
Net Profit Margin (TTM) (%) --
Net Profit Margin (MRQ) (%) --
Net Profit Margin (FY) (%) --
Gross Margin (TTM) (%) --
Gross Margin (MRQ) (%) --
Gross Margin (FY) (%) --
Copyright 2018 by Immunocellular Therapeutics, Ltd.
All Rights Reserved
  
* Site identity: * - front_page: The URL of the front page. Use this instead of base_path when * linking to the front page. This includes the language domain or prefix. * * Page content (in order of occurrence in the default page.html.twig): * - node: Fully loaded node, if there is an automatically-loaded node * associated with the page and the node ID is the second argument in the * page's path (e.g. node/12345 and node/12345/revisions, but not * comment/reply/12345). * * Regions: * - page.header: Items for the header region. * - page.help: Dynamic help text, mostly for admin pages. * - page.content: The main content of the current page. * - page.sidebar_first: Items for the first sidebar. * - page.sidebar_last: Items for the second sidebar. * - page.footer: Items for the footer region. * * @see template_preprocess_page() * @see html.html.twig */ #}

investors

Key Ratios

Price & Volume

Recent Price $0.22
Recent Price 9/24/18
52 Week High $0.55
52 Week Low $0.17
5 Day Price Percent Change (%) 4.81%
4 Week Price Percent Change (%) -8.29%
26 Week Price Percent Change (%) -18.48%
52 Week Price Percent Change (%) -37.11%
Volume (3 Month Average) (Mil) 4.14
Volume (10 Day Average) (Mil) 0.24
Beta -0.09

Dividend Information

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Quick Ratio (FY)) --
Current Ratio (MRQ) $9.53
LT Debt to Equity (MRQ) (%) --
LT Debt to Equity (MRQ) (%) --
LT Debt to Equity (FY) (%) --
Total Debt to Equity (MRQ) (%) --
Total Debt to Equity (FY) (%) --

Valuation Ratios

P/E (TTM) --
P/E (FY) --
P/E 5 Fiscal Year High --
P/E 5 Fiscal Year Low --
Price to Revenue (TTM) --
Price to Revenue (MRQ) --
Price to Revenue (FY) --
Price to Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) --
Price to Free Cash Flow (TTM) --
Price to Free Cash Flow (FY) --
Price to Book (MRQ) $2.69
Price to Book (FY) $1.98
Price to Tangible Book (MRQ) $2.69
Price to Tangible Book (FY) $1.99
Price to Tangible Book - Common (MRQ) $3.18
Price to Tangible Book - Common (FY) $2.85

Per Share Data

Revenue/Share (TTM) --
Revenue/Share (MRQ) --
Revenue/Share (FY) --
EPS Fully Diluted (TTM) $-0.48
EPS Fully Diluted (MRQ) $-0.01
Book Value/Share (MRQ) $0.08
Book Value/Share (FY) $0.11
Cash Flow/Share (TTM) $-0.27
Cash Flow/Share (MRQ) $-0.03
Cash Flow/Share (FY) $-1.22
Cash (MRQ) $0.07
Cash (FY) $0.16

Mgmt Effectiveness

Return on Equity (TTM) (%) -3,687.44
Return on Equity (MRQ) (%) -34.66
Return on Equity (FY) (%) -328.04
Return on Assets (TTM) (%) -131.11
Return on Assets (MRQ) (%) -27.36
Return on Assets (FY) (%) -119.77
Return on Investment (TTM) (%) -2,187.58
Return on Investment (MRQ) (%) -34.66
Return on Investment (FY) (%) -156.42

Profitability

Operating Margin (TTM) (%) --
Operating Margin (MRQ) (%) --
Operating Margin (FY) (%) --
Net Profit Margin (TTM) (%) --
Net Profit Margin (MRQ) (%) --
Net Profit Margin (FY) (%) --
Gross Margin (TTM) (%) --
Gross Margin (MRQ) (%) --
Gross Margin (FY) (%) --
Copyright 2018 by Immunocellular Therapeutics, Ltd.
All Rights Reserved